In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration

References

• Abdallah M, Sammour O, El-Gharmy H, Abu-Saleem M. (2013). Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations. Int J Pharm Sci Res 4:1757–65
   Google Scholar
• Abdelkader H, Ismail S, Hussein A, et al. (2012). Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen’s egg chorioallantoic membrane and excised bovine cornea models. Int J Pharm 432:1–10
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Ismail S, Kamal A, Alany RG. (2011). Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci 100:1833–46
   PubMed Web of Science ®Google Scholar
• Agarwal R, Katare OP, Vyas SP. (2001). Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 228:43–52
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Kaur IP. (2005). Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 290:155–9
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM. (2011). Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–52
   PubMed Web of Science ®Google Scholar
• Arunothayanun P, Turton JA, Uchegbu IF, Florence AT. (1999). Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes. J Pharm Sci 88:34–8
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Shanmugam S, Lee WS, et al. (2009). Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377:1–8
   PubMed Web of Science ®Google Scholar
• Belgamwar VS, Patel HS, Joshi AS, et al. (2011). Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting. Drug Deliv 18:353–60
   PubMed Web of Science ®Google Scholar
• Bendas ER, Abdullah H, El-Komy MH, Kassem MA. (2013). Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Int J Pharm 458:287–95
   PubMed Web of Science ®Google Scholar
• Bernsdorff C, Wolf A, Winter R, Gratton E. (1997). Effect of hydrostatic pressure on water penetration and rotational dynamics in phospholipid-cholesterol bilayers. Biophys J 72:1264–77
   PubMed Web of Science ®Google Scholar
• Boyd RA, Chin SK, Don-Pedro O, et al. (1989). The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose. Clin Pharmacol Ther 46:408–19
   PubMed Web of Science ®Google Scholar
• Chalikwar SS, Mene BS, Pardeshi CV, et al. (2013). Self-assembled, chitosan grafted PLGA nanoparticles for intranasal delivery: design, development and ex vivo characterization. Poly Plast Technol Eng 52:368–80
   Web of Science ®Google Scholar
• Chaw CS, Kim KY. (2012). Effect of formulation compositions on niosomal preparations. Pharm Dev Technol 18:667–72
   PubMed Web of Science ®Google Scholar
• Chougule M, Padhi B, Misra A. (2007). Nano-liposomal dry powder inhaler of tacrolimus: Preparation, characterization, and pulmonary pharmacokinetics. Int J Nanomed 2:675–88
   PubMed Web of Science ®Google Scholar
• Dhakar RC, Maurya SD, Tilak VK, Dupta AK. (2011). A review on factors affecting the design of nasal drug delivery system. Int J Drug Deliv 1:194–208
   Google Scholar
• Dougherty AH, Jackman WM, Naccarelli GV, et al. (1992). Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV diltiazem study group. Am J Cardiol 70:587–92
   PubMed Web of Science ®Google Scholar
• Echizen H, Eichelbaum M. (1986). Clinical pharmacokinetics of verapamil, nifedipine and diltiazem. Clin Pharmacokinet 11:425–49
   PubMed Web of Science ®Google Scholar
• Elhissi A, Hidayat K, Phoenix DA, et al. (2013). Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology. Int J Pharm 444:193–9
   PubMed Web of Science ®Google Scholar
• Essa E. (2010). Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm 4:227–33
   Google Scholar
• Fang JY, Hong CT, Chiu WT, Wang YY. (2001). Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61–72
   PubMed Web of Science ®Google Scholar
• Gurrapu A, Jukanti R, Bobbala S, et al. (2012). Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol 23:583–90
   Web of Science ®Google Scholar
• Haider M, Mohamed M, Ali M. (2014). Formulation and in vitro/in vivo evaluation of buccoadhesive discs for controlled release of calcium channel antagonist. Am J Drug Disc Dev 4: 210–31
   Google Scholar
• Hao Y, Zhao F, Li N, et al. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80
   PubMed Web of Science ®Google Scholar
• Höglund P, Nilsson LG. (1989). Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers. Ther Drug Monit 11:551–7
   PubMed Web of Science ®Google Scholar
• Hong M, Zhu S, Jiang Y, et al. (2009). Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. J Control Release 133:96–102
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen J, Chen X, et al. (2008). PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides. J Mater Sci Mater Med 19:607–14
   PubMed Web of Science ®Google Scholar
• Hussain AA. (1998). Intranasal drug delivery. Adv Drug Deliv Rev 29:39–49
   PubMed Web of Science ®Google Scholar
• Illum L. (2003). Nasal drug delivery-possibilities, problems and solutions. J Control Release 87:187–98
   PubMed Web of Science ®Google Scholar
• Illum L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1–18
   PubMed Web of Science ®Google Scholar
• Jain S, Singh P, Mishra V, Vyas SP. (2005). Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett 101:41–9
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D. (2012). Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm 423:303–11
   PubMed Web of Science ®Google Scholar
• Kamboj S, Saini V, Bala S. (2014). Formulation and characterization of drug loaded nonionic surfactant vesicles (Niosomes) for oral bioavailability enhancement. Scientific World J 1:1–9
   Web of Science ®Google Scholar
• Kazi KM, Mandal AS, Biswas N, et al. (2010). Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 1:374–80
   PubMedGoogle Scholar
• Kulkarni AD, Bari DB, Surana SJ, Pardeshi CV. (2016). In vitro, ex vivo and in vivo performance of chitosan-based spray-dried nasal mucoadhesive microspheres of diltiazem hydrochloride. J Drug Deliv Sci Technol 31:108–17
   Web of Science ®Google Scholar
• Leroux JC, Cozens R, Roesel JL, et al. (1995). Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J Pharm Sci 84:1387–91
   PubMed Web of Science ®Google Scholar
• Mahale NB, Thakkar PD, Mali RG, et al. (2012). Niosomes: novel sustained release nonionic stable vesicular systems - an overview. Adv Colloid Interface Sci 183–184:46–54
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroj J, et al. (2003). Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B 30:129–38
   Web of Science ®Google Scholar
• Manosroi A, Khanrin P, Lohcharoenkal W, et al. (2010). Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 392:304–10
   PubMed Web of Science ®Google Scholar
• Marianecci C, Paolino D, Celia C, et al. (2010). Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release 147:127–35
   PubMed Web of Science ®Google Scholar
• Mei D, Mao S, Sun W, et al. (2008). Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats. Eur J Pharm Biopharm 70:874–81
   PubMed Web of Science ®Google Scholar
• Moghassemi S, Hadjizadeh A. (2014). Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release 185:22–36
   PubMed Web of Science ®Google Scholar
• Mundada AS, Avari JG. (2011). Novel biomaterial for transdermal application: in vitro and in vivo characterization. Drug Deliv 18: 424–31
   PubMed Web of Science ®Google Scholar
• Na L, Mao S, Wang J, et al. (2010). Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats. Int J Pharm 397:59–66
   PubMed Web of Science ®Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–41
   PubMed Web of Science ®Google Scholar
• Parhi R, Suresh P. (2016). Transdermal delivery of diltiazem HCl from matrix film: effect of penetration enhancers and study of antihypertensive activity in rabbit model. J Adv Drug Res 7:539–50
   Google Scholar
• Piao HM, Balakrishnan P, Cho HJ, et al. (2010). Preparation and evaluation of fexofenadine microemulsions for intranasal delivery. Int J Pharm 395:309–16
   PubMed Web of Science ®Google Scholar
• Pinto AG, Horlander J, Chalasani N, et al. (2005). Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein. Br J Clin Pharmacol 59:440–6
   PubMed Web of Science ®Google Scholar
• Pontiroli A. (1998). Peptide hormones: review of current and emerging uses by nasal delivery. Adv Drug Deliv Rev 29:81–7
   PubMed Web of Science ®Google Scholar
• Qiang F, Shin HJ, Lee BJ, Han HK. (2012). Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int J Pharm 430:161–6
   PubMed Web of Science ®Google Scholar
• Romeo VD, deMeireles J, Sileno AP, et al. (1998). Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 29:89–116
   PubMed Web of Science ®Google Scholar
• Ruckmani K, Sankar V. (2010). Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech 11:1119–27
   PubMed Web of Science ®Google Scholar
• Shahiwala A, Misra A. (2002). Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 5:220–5
   PubMed Web of Science ®Google Scholar
• Siegel RA, Rathbone MJ. (2012). Overview of controlled release mechanisms. In: Rathbone MJ, ed. Fundamentals and applications of controlled release drug delivery. New York: Springer, 107–23
   Google Scholar
• Song Y, Wang Y, Thakur R, et al. (2004). Mucosal drug delivery: membranes, methodologies, and applications. Crit Rev Ther Drug Carrier Syst 21:195–256
   PubMedGoogle Scholar
• Ugwoke MI, Agu RU, Verbeke N, Kinget R. (2005). Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev 57:1640–65
   PubMed Web of Science ®Google Scholar
• Vyas SP, Singh RP, Jain S, et al. (2005). Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm 296:80–6
   PubMed Web of Science ®Google Scholar
• Waddad AY, Abbad S, Yu F, et al. (2013). Formulation, characterization and pharmacokinetics of morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm 456:446–58
   PubMed Web of Science ®Google Scholar
• Walker W, Brewer JM, Alexander J. (1996). Lipid vesicle-entrapped influenza A antigen modulates the influenza A-specific human antibody response in immune reconstituted SCID-human mice. Eur J Immunol 26:1664–7
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg BB, Florence T. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm 105:1–6
   Web of Science ®Google Scholar
• Zhang HY, Liao P, Wang JJ, et al. (2010). Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca(v)1.2 calcium channels. Br J Pharmacol 160:1631–40
   PubMed Web of Science ®Google Scholar